TARO - Taro Pharmaceutical hits 52-week low; down 28% YTD
- Taro Pharmaceutical ( NYSE: TARO ) on Monday hit a 52-week low of $32.50.
- The Israeli drugmaker, known for marking generic and over-the-counter products, is down ~28% year to date.
- Taro ( TARO ) beat on the top and bottom lines in its Q2 2022 results at the end of July.
For further details see:
Taro Pharmaceutical hits 52-week low; down 28% YTD